MAPP BIOPHARMACEUTICAL, INC.

MAPP BIOPHARMACEUTICAL, INC. is a biotech company in San Diego, United States, founded in 2015. It has raised $41.5M across 11 rounds, most recently a $993K Grant in September 2025.

Employees
51–200
Founded
2015
Total Funding
$41.5M
Last Round
$993K GrantSep 2025
Rounds
11

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 11 funding rounds and 3 investors for this company. The full record is or through the API.

About

Mapp Biopharmaceutical develops novel pharmaceuticals to prevent and treat infectious diseases, focusing on unmet needs in global health and biodefense. Its development work includes a novel Nipah monoclonal antibody and a therapeutic for Marburg virus disease, which it is advancing in collaboration with BARDA.

Summary

It lists 51–200 employees. It has raised $41.5M in total across 11 rounds, most recently a $993K Grant round in Sep 2025. Investors include Department of Health and Human Services, U.S. Department of Defense and Defense Threat Reduction Agency.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase II (NIH)Sep 2025
$993K

Sign up to see all 11 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MAPP BIOPHARMACEUTICAL, INC. on Indexed.vc
<a href="https://indexed.vc/companies/mapp-biopharmaceutical-inc"><img src="https://indexed.vc/api/badge/company/mapp-biopharmaceutical-inc" alt="MAPP BIOPHARMACEUTICAL, INC. on Indexed.vc" width="260" height="76" /></a>